{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:54:42Z","timestamp":1781632482544,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate characteristics of diffusion kurtosis imaging (DKI), baseline prostate-specific antigen (PSA) and postoperative histopathological findings associated with biochemical recurrence (BCR) of prostate cancer (PCa) after radical prostatectomy (RP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials &amp; Methods<\/jats:title>\n                    <jats:p>Totally, 44 BCR patients and 72 non-BCR patients who underwent RP from April 2019 to March 2021 were retrospective collected. Baseline PSA, parameters of DKI and histopathological characteristics of the patients were evaluated. Continuous variables were compared by independent sample t-test, and categorical variables were compared by Chi-square test and Fisher's exact test. Cox regression analysis was used to analyze the association between relevant characteristics and BCR. p&lt;0.05 was considered statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Results of univariate Cox regression analysis showed that baseline T-PSA (p&lt;0.001), F-PSA (p=0.034), F\/T-PSA (p&lt;0.001), mean diffusivity (MD) (p=0.002), mean kurtosis (MK) (p&lt;0.001) and apparent diffusion coefficient (ADC) (p=0.021) values, ISUP grade group 4 or 5 (p&lt;0.001), positive extraprostatic extension (EPE) (p&lt;0.001), positive perineural invasion (p=0.041), Positive surgical margin (p=0.001) and positive lymphovascular invasion (p&lt;0.001) were correlated with BCR. However, results of multivariate Cox regression analysis showed that baseline T-PSA (HR=10.579; 95% CI, 4.405\u201327.670; p&lt;0.001), MK value (HR=3.034; 95% CI, 1.809\u20135.089; p&lt;0.001), ISUP grade group 4 or 5 (HR=3.121; 95% CI, 1.352\u20137.209; p=0.008), positive EPE (HR=2.219; 95% CI, 1.058\u20134.651; p=0.035) and positive surgical margin (HR=2.816; 95% CI, 1.585\u20134.845; p=0.025) were independent risk factors for BCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MK value, as well as baseline F-PSA, ISUP grade group 4 or 5, positive EPE and surgical margin were associated with BCR of PCa after RP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40644-026-00997-y","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T19:15:07Z","timestamp":1769627707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic features of biochemical recurrence of prostate cancer following radical prostatectomy based on diffusion kurtosis imaging"],"prefix":"10.1186","volume":"26","author":[{"given":"Li-Peng","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Wen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Kun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Peng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"issue":"1","key":"997_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"997_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and local treatment with curative intent. Eur Urol. 2024;86(2):148\u201363.","journal-title":"Eur Urol"},{"issue":"2","key":"997_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","volume":"86","author":"D Tilki","year":"2024","unstructured":"Tilki D, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II-2024 update: treatment of relapsing and metastatic prostate cancer. Eur Urol. 2024;86(2):164\u201382.","journal-title":"Eur Urol"},{"issue":"2","key":"997_CR4","doi-asserted-by":"publisher","first-page":"e223349","DOI":"10.1148\/radiol.223349","volume":"309","author":"S Luzzago","year":"2023","unstructured":"Luzzago S, Colombo A, Mistretta FA, Alessi S, Di Trapani E, Summers PE, et al. Multiparametric MRI-based 5-year risk prediction model for biochemical recurrence of prostate cancer after radical prostatectomy. Radiology. 2023;309(2):e223349.","journal-title":"Radiology"},{"issue":"5","key":"997_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1607529","volume":"376","author":"WU Shipley","year":"2017","unstructured":"Shipley WU, Seiferheld W, Lukka HR, Major PP, Heney NM, Grignon DJ, et al. Radiation with or without antiandrogen therapy in recurrent prostate cancer. N Engl J Med. 2017;376(5):417\u201328.","journal-title":"N Engl J Med"},{"issue":"10442","key":"997_CR6","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/S0140-6736(24)00549-X","volume":"403","author":"CC Parker","year":"2024","unstructured":"Parker CC, Kynaston H, Cook AD, Clarke NW, Catton CN, Cross WR, et al. Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial. Lancet. 2024;403(10442):2416\u201325.","journal-title":"Lancet"},{"key":"997_CR7","doi-asserted-by":"crossref","unstructured":"Kachanov M, Volk AE, Falkenbach F, Mollring A, Hauke J, Rading K et al. Evaluation of different National comprehensive cancer network clinical practice guidelines in prostate cancer for germline genetic testing in localized and locally recurrent prostate cancer. Eur Urol Focus. 2025.","DOI":"10.1016\/j.euf.2025.05.021"},{"issue":"1","key":"997_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/JU.0000000000002758","volume":"208","author":"JA Eastham","year":"2022","unstructured":"Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, Davis JW, et al. Clinically localized prostate cancer: AUA\/ASTRO Guideline, part II: principles of active Surveillance, principles of Surgery, and Follow-Up. J Urol. 2022;208(1):19\u201325.","journal-title":"J Urol"},{"key":"997_CR9","doi-asserted-by":"crossref","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol. 2019;76(3):340\u201351.","DOI":"10.1016\/j.eururo.2019.02.033"},{"issue":"1","key":"997_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00261-024-04454-x","volume":"50","author":"P Rajabi","year":"2025","unstructured":"Rajabi P, Rezakhaniha B, Galougahi MHK, Mohammadimehr M, Sharifnia H, Pakzad R, et al. Unveiling the diagnostic potential of diffusion kurtosis imaging and intravoxel incoherent motion for detecting and characterizing prostate cancer: a meta-analysis. Abdom Radiol (NY). 2025;50(1):319\u201335.","journal-title":"Abdom Radiol (NY)"},{"issue":"12","key":"997_CR11","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1007\/s00261-020-02776-0","volume":"45","author":"H Park","year":"2020","unstructured":"Park H, Kim SH, Lee Y, Son JH. Comparison of diagnostic performance between diffusion kurtosis imaging parameters and mono-exponential ADC for determination of clinically significant cancer in patients with prostate cancer. Abdom Radiol (NY). 2020;45(12):4235\u201343.","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"997_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1148\/radiol.2017162321","volume":"284","author":"T Tamada","year":"2017","unstructured":"Tamada T, Prabhu V, Li J, Babb JS, Taneja SS, Rosenkrantz AB. Prostate cancer: Diffusion-weighted MR imaging for detection and assessment of Aggressiveness-Comparison between conventional and kurtosis models. Radiology. 2017;284(1):100\u20138.","journal-title":"Radiology"},{"issue":"10","key":"997_CR13","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1007\/s00261-019-02075-3","volume":"44","author":"Y Shan","year":"2019","unstructured":"Shan Y, Chen X, Liu K, Zeng M, Zhou J. Prostate cancer aggressive prediction: preponderant diagnostic performances of intravoxel incoherent motion (IVIM) imaging and diffusion kurtosis imaging (DKI) beyond ADC at 3.0 T scanner with Gleason score at final pathology. Abdom Radiol (NY). 2019;44(10):3441\u201352.","journal-title":"Abdom Radiol (NY)"},{"issue":"10","key":"997_CR14","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1007\/s00261-025-04901-3","volume":"50","author":"Z Gong","year":"2025","unstructured":"Gong Z, Jiang F, Liu Z, Chen Z, Peng Y, Qiu J, et al. Exploring the value of multiparametric quantitative magnetic resonance imaging in avoiding unnecessary biopsy in patients with PI-RADS 3\u20134. Abdom Radiol (NY). 2025;50(10):4731\u201341.","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"997_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12880-025-01881-0","volume":"25","author":"KP Zhou","year":"2025","unstructured":"Zhou KP, Huang HB, Li SY, Luo ZX, Cheng XW, Liu DM, et al. Non-invasive MRI-based assessment of reactive stromal grade in prostate cancer using diffusion kurtosis imaging and stretched-exponential model. BMC Med Imaging. 2025;25(1):339.","journal-title":"BMC Med Imaging"},{"issue":"5","key":"997_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","volume":"17","author":"JL Mohler","year":"2019","unstructured":"Mohler JL, Antonarakis ES, Armstrong AJ, D\u2019Amico AV, Davis BJ, Dorff T, et al. Prostate Cancer, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(5):479\u2013505.","journal-title":"J Natl Compr Canc Netw"},{"key":"997_CR17","doi-asserted-by":"crossref","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA, et al. The 2014 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40(2):244\u201352.","DOI":"10.1097\/PAS.0000000000000530"},{"issue":"3","key":"997_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","volume":"22","author":"EM Schaeffer","year":"2024","unstructured":"Schaeffer EM, Srinivas S, Adra N, An Y, Bitting R, Chapin B, et al. NCCN Guidelines(R) insights: prostate Cancer, version 3.2024. J Natl Compr Canc Netw. 2024;22(3):140\u201350.","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"997_CR19","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/mrm.20508","volume":"53","author":"JH Jensen","year":"2005","unstructured":"Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med. 2005;53(6):1432\u201340.","journal-title":"Magn Reson Med"},{"issue":"8","key":"997_CR20","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1007\/s00330-017-5169-1","volume":"28","author":"T Barrett","year":"2018","unstructured":"Barrett T, McLean M, Priest AN, Lawrence EM, Patterson AJ, Koo BC, et al. Diagnostic evaluation of magnetization transfer and diffusion kurtosis imaging for prostate cancer detection in a re-biopsy population. Eur Radiol. 2018;28(8):3141\u201350.","journal-title":"Eur Radiol"},{"key":"997_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejrad.2019.07.009","volume":"118","author":"K Ding","year":"2019","unstructured":"Ding K, Yao Y, Gao Y, Lu X, Chen H, Tang Q, et al. Diagnostic evaluation of diffusion kurtosis imaging for prostate cancer: detection in a biopsy population. Eur J Radiol. 2019;118:138\u201346.","journal-title":"Eur J Radiol"},{"issue":"10","key":"997_CR22","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1177\/0284185120901504","volume":"61","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Li C, Liu Y, Shi K, Zhang W, Liu M, et al. Histogram analysis in prostate cancer: a comparison of diffusion kurtosis imaging model versus monoexponential model. Acta Radiol. 2020;61(10):1431\u201340.","journal-title":"Acta Radiol"},{"issue":"6","key":"997_CR23","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1007\/s00261-020-02903-x","volume":"46","author":"G Liu","year":"2021","unstructured":"Liu G, Lu Y, Dai Y, Xue K, Yi Y, Xu J, et al. Comparison of mono-exponential, bi-exponential, kurtosis, and fractional-order calculus models of diffusion-weighted imaging in characterizing prostate lesions in transition zone. Abdom Radiol (NY). 2021;46(6):2740\u201350.","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"997_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.juro.2018.08.043","volume":"201","author":"I Faiena","year":"2019","unstructured":"Faiena I, Salmasi A, Mendhiratta N, Markovic D, Ahuja P, Hsu W, et al. PI-RADS version 2 category on 3 Tesla multiparametric prostate magnetic resonance imaging predicts oncologic outcomes in Gleason 3\u2009+\u20094 prostate cancer on biopsy. J Urol. 2019;201(1):91\u20137.","journal-title":"J Urol"},{"issue":"5","key":"997_CR25","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.juro.2017.10.042","volume":"199","author":"N Tan","year":"2018","unstructured":"Tan N, Shen L, Khoshnoodi P, Alcala HE, Yu W, Hsu W, et al. Pathological and 3 Tesla volumetric magnetic resonance imaging predictors of biochemical recurrence after robotic assisted radical prostatectomy: correlation with whole Mount histopathology. J Urol. 2018;199(5):1218\u201323.","journal-title":"J Urol"},{"issue":"3","key":"997_CR26","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1148\/radiol.2021202425","volume":"299","author":"SA Harmon","year":"2021","unstructured":"Harmon SA, Gesztes W, Young D, Mehralivand S, McKinney Y, Sanford T, et al. Prognostic features of biochemical recurrence of prostate cancer following radical prostatectomy based on multiparametric MRI and immunohistochemistry analysis of MRI-guided biopsy specimens. Radiology. 2021;299(3):613\u201323.","journal-title":"Radiology"},{"issue":"11","key":"997_CR27","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D\u2019Amico","year":"1998","unstructured":"D\u2019Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969\u201374.","journal-title":"JAMA"},{"issue":"10","key":"997_CR28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/jnci\/djj190","volume":"98","author":"AJ Stephenson","year":"2006","unstructured":"Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr., Dotan ZA, Fearn PA, et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst. 2006;98(10):715\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"997_CR29","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1097\/01.ju.0000158155.33890.e7","volume":"173","author":"MR Cooperberg","year":"2005","unstructured":"Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, et al. The university of California, San Francisco cancer of the prostate risk assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol. 2005;173(6):1938\u201342.","journal-title":"J Urol"},{"issue":"12","key":"997_CR30","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1001\/jamaoncol.2020.4922","volume":"6","author":"RT Dess","year":"2020","unstructured":"Dess RT, Suresh K, Zelefsky MJ, Freedland SJ, Mahal BA, Cooperberg MR, et al. Development and validation of a clinical prognostic stage group system for nonmetastatic prostate cancer using Disease-Specific mortality results from the international staging collaboration for cancer of the prostate. JAMA Oncol. 2020;6(12):1912\u201320.","journal-title":"JAMA Oncol"},{"issue":"4","key":"997_CR31","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.eururo.2021.06.008","volume":"80","author":"C Wurnschimmel","year":"2021","unstructured":"Wurnschimmel C, Pose RM, Wenzel M, Tian Z, Incesu RB, Karakiewicz P, et al. Validation of the STAR-CAP clinical prognostic system for predicting biochemical Recurrence, Metastasis, and Cancer-specific mortality after radical prostatectomy in a European cohort. Eur Urol. 2021;80(4):400\u20134.","journal-title":"Eur Urol"},{"issue":"6","key":"997_CR32","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0090-4295(01)01441-8","volume":"58","author":"AW Partin","year":"2001","unstructured":"Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology. 2001;58(6):843\u20138.","journal-title":"Urology"},{"key":"997_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.euros.2024.09.007","volume":"69","author":"J Karwacki","year":"2024","unstructured":"Karwacki J, Stodolak M, Dlubak A, Nowak L, Gurwin A, Kowalczyk K, et al. Association of lymphovascular invasion with biochemical recurrence and adverse pathological characteristics of prostate cancer: A systematic review and Meta-analysis. Eur Urol Open Sci. 2024;69:112\u201326.","journal-title":"Eur Urol Open Sci"},{"issue":"6","key":"997_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.urolonc.2018.02.008","volume":"36","author":"LC Peng","year":"2018","unstructured":"Peng LC, Narang AK, Gergis C, Radwan NA, Han P, Marciscano AE, et al. Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy. Urol Oncol. 2018;36(6):309. e7- e14.","journal-title":"Urol Oncol"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-026-00997-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-00997-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-00997-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:17:20Z","timestamp":1781630240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40644-026-00997-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["997"],"URL":"https:\/\/doi.org\/10.1186\/s40644-026-00997-y","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the\n                      Institutional Ethics Committee of the Second Affiliated Hospital of Dalian Medical University\n                      (PR\/AG- 342\/2020, approved on 3 February 2020), and in accordance with the Declaration of Helsinki. Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}